Digitally Enabled Access
To drive equitable patient access to cancer care and clinical trials, your health system can leverage digital health solutions to:
Objective 1: Expedite Time to Diagnosis & Treatment
Digital Solution Value Proposition: AI-Enabled Screening & Diagnosis Solutions to Expedite Time to Treatment
AI-enabled screening processes can expedite time to diagnosis and treatment and have resulted in overall cost savings to health systems and patients.
How to deploy: Approaches to AI/ML Deployment
Natural language processing algorithms can be used to scrub structured and unstructured EHR data to flag at-risk patients eligible for screening.
More here for a technical basis to support this approach.
Digital Solution Value Proposition: EHR-Embedded Solutions To Expedite Time to Treatment
EHR-embedded solutions can address inefficiencies and breakdowns in the specialist referral process. They also act as clinical decision support for providers in developing treatment plans to enable equitable access to guidance-concordant precision care.
How to deploy: Approaches to EHR- Embedded Solution Deployment
Automated referral solutions are portable and can be launched directly from the EHR.
They support referral coordinators by extracting relevant patient and referring provider data and tracking patient encounters.
Traditional approaches to clinical practice guideline deployment results in approximately half of all patients not receiving recommended care.
CDS solutions have shown promise in predicting therapeutic response and have proven effective in replicating multidisciplinary cancer team treatment decisions. More here for an example of an off-the-shelf EHR-embedded clinicalObjective 2: Expand the Care Footprint
Digital Solution Value Proposition: Virtual Care to Expand the Care Footprint
How to deploy: Approaches to Virtual Care Deployment
This approach facilitates remote expert reviews of cancer cases. It also supports the development of treatment plans by a specialist provider to be executed by a general oncologist closer to the patient’s home
Telehealth programming is especially beneficial for patients in rural communities, who are disproportionately impacted by the indirect costs of cancer care, due to reduced need for travel.
City of Hope Case Study: AccessHope and Expanding the Care Footprint To Extend the Survival Advantage
Case Study: City of Hope
AccessHope and Expanding the Care Footprint To Extend the Survival Advantage
The Challenge: There is a significant survival advantage for the 20% of cancer patients treated at NCI-designated comprehensive care centers.
- The Approach
- Program Workflow
- Resource Commitments
- The Results
AccessHope provides remote expert case reviews for complex cancers automatically via claims data, or by member request, as well as ongoing connection to knowledge and support throughout a patient’s cancer journey.
Staff Requirements
- Local community oncologists
- Subspecialty oncologists from NCI-CCC partners of AccessHope
- Employers, health plans, third-party administrators, health care platforms, and health care services companies
Measurements of Effectiveness
- 89 Net Promoter Score (world-class rating for member satisfaction)
- 97% level of discordance with treating oncologist treatment plan
- 88% treating oncologist adoption of recommended changes
- 1.5 : 1 return on investment
Technology Requirements
- Proprietary algorithm to identify and automatically review most-complex cancers
- Physician portal for expert case reviews
- Online member support and live oncology nurse support
- HITRUST Risk-Based Certification; SOC 2 Type I Certification
Other Considerations
- Implementation in 90–120 days for organizations interested in participating in AccessHope
- Benefit ecosystem connectivity to fully support member journey during cancer
Clinical improvements
- 88% of AccessHope’s clinical recommendations were incorporated into treatment plans.
- 91.1% of these recommendations improved cancer outcomes and likelihood of a cure.
Cost Savings
- Nearly $150K per case and $19K per patient due to the elimination of low value interventions.
Objective 3: Extend Clinical Trial Opportunities
Digital Solution Value Proposition: Patient-Centric Digital Solutions to Extend Clinical Trial Opportunities
Direct-to-patient solutions, AI/ML algorithms, and remote patient monitoring can be used to:
-
Extend access to cancer clinical trials.
-
Improve trial participation rates (currently between 3% and 5% of cancer patients).
- Enhance the evidence base for precision cancer care.
How to deploy: Approaches to Patient-Centric Solution Deployment
The use of natural language processing software for automated trial matching is nascent but promising for increasing the number of patients screened and connected with clinical trial opportunities.
Systems can leverage end-to-end DCT platforms to support remote patient monitoring and at-home clinical trial participation.
This can reduce barriers to participation, expand the number of clinical trials opened, and expedite trial conduct. There are several DCTs platforms available on the market – check our solutions catalog for more information.
Patients and caregivers consistently report gaps in provider awareness and their own knowledge of clinical trial opportunities.
Health system providers can connect patients with free, third-party solutions containing information about clinical trial opportunities
Atrium Health Levine Cancer Case Study: Digital Genomics Program and Extending Access to Clinical Trials
Case Study: Atrium Health Levine Cancer
Digital Genomics Program and Extending Access to Clinical Trials
The Challenge: Lack of (or lags) in molecular testing prevent patients from receiving targeted immunotherapy or being matched to molecularly-driven trials.
- The Approach
- Program Workflow
- Resource Commitments
- The Results
The Approach: To implement clinical genomics testing across a multi-state oncology group, Atrium Levine Health provided centralized, standardized support to providers and integrated digital solutions with clinical workflows to decrease known barriers to use (e.g. lack of training, physician confidence, gaps in decision support, high workload, EHR alert fatigue, cost to patient)
The Approach: Atrium Levine Health integrated the testing program with clinical workflows, increased patient connections to financial assistance, and provided real-time decision support to clinicians by:
The Approach:
- Standardizing and integrating order sets, including a financial assistance application, into clinical pathways and the EHR.
-
Standardizing and centralizing the workflow for obtaining specimens, sending for testing, and tracking progress of the process to ensure rapid turn-around-time and clinical implementation of test results.
Orders were automatically sent to a centralized genomics team, teams performing biopsies to obtain specimens for sequencing, and a genetics team to coordinate somatic/germline testing.
- Ensuring results and reports from third-party diagnostic companies were sent electronically, imported into a custom, in-house developed app. to form summary report and merged with clinical data (e.g., diagnosis, prior treatments, lab results, etc) to provide clinical trial matches in real-time pushed to EHR.
- Integrating a quick link was into the summary report, clinical pathways, and EHR so that providers could obtain Molecular Tumor Board (MTB) review with a simple mouse click during clinical care for patients.
Staff Requirements
- Providers and nurses at all levels of experience
- IT staff and staff familiar with understanding of genomics use in clinical setting
- Third-party genomics test companies or internal molecular pathology team
Technology Requirements
-
An EHR-embedded application for treatment and trial matching to genomics results
-Developed using software typically available with minimal additional cost at most institutions : MS suite; Power Apps, Power BI, SharePoint, SQL Server, Azure, Data factory and Databricks
- API/HL7/Secure File Transfer Portal /MS Data factory for data transfer
- Updates of new drug approvals and clinical trial enrollment status made available in trial matching application
Improved use and ease of access to genomic testing for patients and providers
- 11-fold increase in genomic testing across the system post-program implementation.
Generated substantial improvements in clinical trial accrual
- 15% of patients with genomic testing enrolled in a clinical trial; 28% of patients reviewed by MTB enrolled in a clinical trial.
Promoted equity in access to cancer treatment
- The patient population that underwent genomic testing closely matched Atrium Levine Health’s patient population demographics by race and ethnicity (16% Black/African American, 4% Hispanic/Latino) Nationally, there are significant disparities in the receipt of molecular testing.
Reduce patient financial toxicity
- Greater than 90% of patients paid $0 out-of-pocket due to robust financial assistance from third-party genomics test vendors and integration into clinical workflow.
Objective 4: Bridge the Digital Divide
Increasing Solution Uptake by Bridging the Digital Divide
The Digital Divide describes unequal access to the technology used to support digitally-enabled care and is often linked with lower socioeconomic status, insurance status, and low health literacy.
Patients impacted by the digital divide, especially those with lower English proficiency, need additional health system support for digital health solution use.
How to deploy: Approaches to Bridging the Digital Divide
The use of digital health solutions in objectives 1-3 support improved access to care but is impacted by The Digital Divide.
Health systems must account for this in solution deployment.
- Convene virtual health task forces to assess and address barriers to patient uptake of virtual health services. Equip these task forces with the following resources to assess and enhance patient digital health literacy and readiness.
- Opt for vendors that offer materials in multiple languages and/or translation services for real-time translation during telehealth visits.
-
Develop outreach and training materials for patients with lower health and technology literacy who are less likely to use digital solutions.
This checklist for inclusive patient engagement can help your system ensure that all patients are supported via these materials.
These efforts might include providing one-on-one audio or visual education about how to download a mobile application, access the patient health portal, create email accounts, and engage in”practice” visits.
- Ensure comprehensive access features for all deployed solutions, including audio and visual supports for those with disabilities.
Defining Success & Choosing Solutions
Key performance indicators (KPIs) can be used to measure successful digital health solution implementation. Select KPIs that:
Are measurable
Align with existing data workflows
Work within your system’s existing strategy to improve patient access
Key Examples:
- % Increase in the number of patients screened for breast, cervical, colorectal, and lung cancer.
- % Increase in proportion of patients participating in cancer clinical trials (opened within or outside of system).
- % Reduction in time from diagnosis to first line treatment.
- % Reduction in time from patient diagnosis to clinical trial match (where appropriate).
- % Reduction in pathologist report turnaround time (inclusive of molecular profiling report).
- % Increase in the number of visits completed virtually.
- % Increase in proportion of trial recruitment and enrollment materials available in a non-English language.
Access Example Solutions
Here is a guide of existing solutions to expedite time to diagnosis and treatment; support the provision of high-quality virtual care; and extend clinical research options.
Digital Genetics Platform to Expedite Diagnosis & Treatment
Digital Imaging Platform to Guide Expedited Diagnosis & Treatment
Clinical Decision Support for Diagnosis
Clinical Decision Support for Treatment Planning
Clinical Decision Support for Treatment Planning
Digital Platform for Diagnosis
Clinical Decision Support for Treatment Planning
AI/ML Algorithm for Clinical Trial Matching
Digital Solution for Clinical Trial Site Activation
Remote Patient Monitoring for Earlier Intervention
Remote Patient Monitoring & Decentralized Clinical Trials
Remote Patient Monitoring & Decentralized Clinical Trials
Virtual Site for Decentralized Clinical Trials
Virtual Care Platform to Improve Access & Reduce Cost of Treatment
Digital Platform to Improve Access & Reduce Cost of Treatment
Digital Platform to Improve Access & Reduce Cost of Treatment
Virtual Care Platform to Improve Access & Reduce Cost of Treatment
Digital Platform to Improve Access & Reduce Cost of Treatment
Virtual Care Platform to Improve Access to Care in Survivorship
At-Home Screening & Detection Tests
Direct-to-Patient Solution to Improve Patient Cost & Psychosocial Outcomes
Digital Marketplace for Clinical Trials
Patient Navigation Application: Financial Guidance
Patient Navigation Application: Clinical & Financial Guidance
Patient Navigation Application: Psychosocial Guidance
Patient Navigation Application: Clinical & Financial Guidance
Patient Navigation Application: Clinical & Financial Guidance
Patient Navigation Application: Clinical & Psychosocial Guidance
Patient Navigation Application: Patient Access & Reduced Health Care Cost
Digital Solution for Psychosocial Support
Point of Care Solution for Patient Data Sharing
AI-driven Cancer Diagnostic Platform
Digital Platform to Improve Access to Precision Oncology as Part of Treatment Planning